Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goodwin

Showing results (821-830 of 851) with videos related to

Pageof 86
Sort By:
Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Nature Reviews. Drug Discovery|February 2, 2012
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapyMark J Millan, Yves Agid, Martin Brüne, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
Journal of Psychopharmacology (Oxford, England)|March 17, 2016
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyG M Goodwin, P M Haddad, I N Ferrier, et al.
JAMIA Open|January 11, 2021
The case for open science: rare diseasesYaffa R Rubinstein, Peter N Robinson, William A Gahl, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2021
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders networkLars Vedel Kessing, Ana González-Pinto, Andrea Fagiolini, et al.
Cancer Research|November 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic CancerSzu-Aun Long, Haley Todd, Grace Goodhart, et al.
Cell Reports|June 20, 2020
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant CancersIrem Ozkan-Dagliyan, J Nathaniel Diehl, Samuel D George, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 16, 2020
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionMirko Manchia, Eduard Vieta, Olav B Smeland, et al.
Cell Reports|December 1, 2021
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatmentJennifer E Klomp, Ye S Lee, Craig M Goodwin, et al.
Pageof 86

Showing results (821-830 of 851) with videos related to

Sort By:
Pageof 86
Journal of Affective Disorders|March 25, 2026
The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Nature Reviews. Drug Discovery|February 2, 2012
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapyMark J Millan, Yves Agid, Martin Brüne, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
Journal of Psychopharmacology (Oxford, England)|March 17, 2016
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyG M Goodwin, P M Haddad, I N Ferrier, et al.
JAMIA Open|January 11, 2021
The case for open science: rare diseasesYaffa R Rubinstein, Peter N Robinson, William A Gahl, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2021
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders networkLars Vedel Kessing, Ana González-Pinto, Andrea Fagiolini, et al.
Cancer Research|November 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic CancerSzu-Aun Long, Haley Todd, Grace Goodhart, et al.
Cell Reports|June 20, 2020
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant CancersIrem Ozkan-Dagliyan, J Nathaniel Diehl, Samuel D George, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 16, 2020
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionMirko Manchia, Eduard Vieta, Olav B Smeland, et al.
Cell Reports|December 1, 2021
CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatmentJennifer E Klomp, Ye S Lee, Craig M Goodwin, et al.
Pageof 86